AbbVie Header AbbVie Header

X

Find the latest Drugs in Development and Pipeline Prospector News of Hefei Tianmai Biotechnology Development.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Hefei Tianmai Biotechnology Development
China Flag
Country
Country
China
Address
Address
No. 199, Fanhua Avenue, Hefei Economic andTechnological Development Zone, Hefei City, Anhui Province
Telephone
Telephone
+86(551)63849080
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

ORMD-0801 (oral insulin) capsule, with enhanced patient compliance, is currently undergoing phase III clinical trials for the T2DM indication. Drug has the potential to delay the disease progression or even eliminating late-stage complications.


Lead Product(s): Insulin

Therapeutic Area: Endocrinology Product Name: ORMD-0801

Highest Development Status: Phase IIIProduct Type: Peptide

Partner/Sponsor/Collaborator: Oramed Pharmaceuticals

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 15, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY